Anteris Technologies Global Corp.
NASDAQ: AVR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Wayne Geoffrey Paterson
- Employees
- 136
- Headquarters
- Toowong, Australia
- IPO year
- 2024
- Market cap
- $382.6M
- Website
- https://anteristech.com
Loading AVR…
Loading profile data…Frequently asked questions about AVR
What does Anteris Technologies Global Corp. (AVR) do?
Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to...
Where does AVR trade?
Anteris Technologies Global Corp. (AVR) trades on the NASDAQ Global Market.
What sector is AVR in?
Anteris Technologies Global Corp. (AVR) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Anteris Technologies Global Corp.?
Wayne Geoffrey Paterson is the chief executive officer of Anteris Technologies Global Corp. (AVR).
Where is Anteris Technologies Global Corp. headquartered?
Anteris Technologies Global Corp. is headquartered in Australia.
Does AVR pay a dividend?
Anteris Technologies Global Corp. (AVR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AVR go public?
Anteris Technologies Global Corp. (AVR) completed its initial public offering in 2024.